|
PURB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.975100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.10060000000101E-05 |
| Normal-vs-Stage2 |
2.306400E-01 |
| Normal-vs-Stage3 |
6.533800E-01 |
| Normal-vs-Stage4 |
7.459400E-01 |
| Stage1-vs-Stage2 |
3.472200E-01 |
| Stage1-vs-Stage3 |
1.244110E-03 |
| Stage1-vs-Stage4 |
4.20690000000334E-05 |
| Stage2-vs-Stage3 |
3.548200E-01 |
| Stage2-vs-Stage4 |
1.761250E-01 |
| Stage3-vs-Stage4 |
4.822000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.796300E-03 |
| Normal-vs-AfricanAmerican |
3.919200E-01 |
| Normal-vs-Asian |
2.854600E-01 |
| Caucasian-vs-AfricanAmerican |
4.237200E-01 |
| Caucasian-vs-Asian |
9.697000E-01 |
| AfricanAmerican-vs-Asian |
7.063000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.628100E-02 |
| Normal-vs-Female |
7.615900E-04 |
| Male-vs-Female |
5.140400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.882600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.543600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.354100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.811200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.082000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.630600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.851600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.432800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.755800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.718300E-02 |
| Normal-vs-Grade 2 |
1.72429999999446E-05 |
| Normal-vs-Grade 3 |
3.256000E-01 |
| Normal-vs-Grade 4 |
1.953810E-01 |
| Grade 1-vs-Grade 2 |
2.800000E-01 |
| Grade 1-vs-Grade 3 |
6.147700E-02 |
| Grade 1-vs-Grade 4 |
1.720070E-02 |
| Grade 2-vs-Grade 3 |
1.605100E-04 |
| Grade 2-vs-Grade 4 |
2.20819999952049E-07 |
| Grade 3-vs-Grade 4 |
3.462300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.33899999660892E-08 |
| Normal-vs-ccB subtype |
7.690200E-01 |
| ccA subtype-vs-ccB subtype |
4.75869999960743E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.567990E-02 |
| Normal-vs-N1 |
4.394800E-01 |
| N0-vs-N1 |
1.101980E-01 |
|
|
